nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—ACHE—Irinotecan—pancreatic cancer	0.25	0.396	CbGbCtD
Rivastigmine—BCHE—Irinotecan—pancreatic cancer	0.15	0.239	CbGbCtD
Rivastigmine—CYP2D6—Tamoxifen—pancreatic cancer	0.0468	0.0743	CbGbCtD
Rivastigmine—CYP2D6—Erlotinib—pancreatic cancer	0.0398	0.0632	CbGbCtD
Rivastigmine—CYP3A4—Tamoxifen—pancreatic cancer	0.0298	0.0473	CbGbCtD
Rivastigmine—CYP3A4—Erlotinib—pancreatic cancer	0.0253	0.0402	CbGbCtD
Rivastigmine—CYP3A4—Irinotecan—pancreatic cancer	0.0229	0.0363	CbGbCtD
Rivastigmine—CYP2D6—Doxorubicin—pancreatic cancer	0.0197	0.0312	CbGbCtD
Rivastigmine—CYP3A4—Docetaxel—pancreatic cancer	0.0168	0.0266	CbGbCtD
Rivastigmine—CYP3A4—Sunitinib—pancreatic cancer	0.0167	0.0265	CbGbCtD
Rivastigmine—CYP3A4—Doxorubicin—pancreatic cancer	0.0125	0.0198	CbGbCtD
Rivastigmine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000109	0.000296	CcSEcCtD
Rivastigmine—Oedema—Docetaxel—pancreatic cancer	0.000109	0.000296	CcSEcCtD
Rivastigmine—Weight increased—Doxorubicin—pancreatic cancer	0.000109	0.000296	CcSEcCtD
Rivastigmine—Epistaxis—Epirubicin—pancreatic cancer	0.000109	0.000295	CcSEcCtD
Rivastigmine—Pruritus—Gemcitabine—pancreatic cancer	0.000109	0.000295	CcSEcCtD
Rivastigmine—Infection—Docetaxel—pancreatic cancer	0.000109	0.000294	CcSEcCtD
Rivastigmine—Weight decreased—Doxorubicin—pancreatic cancer	0.000109	0.000294	CcSEcCtD
Rivastigmine—Sinusitis—Epirubicin—pancreatic cancer	0.000109	0.000294	CcSEcCtD
Rivastigmine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000108	0.000293	CcSEcCtD
Rivastigmine—Diarrhoea—Irinotecan—pancreatic cancer	0.000108	0.000293	CcSEcCtD
Rivastigmine—Pneumonia—Doxorubicin—pancreatic cancer	0.000108	0.000291	CcSEcCtD
Rivastigmine—Shock—Docetaxel—pancreatic cancer	0.000108	0.000291	CcSEcCtD
Rivastigmine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000107	0.00029	CcSEcCtD
Rivastigmine—Pruritus—Fluorouracil—pancreatic cancer	0.000107	0.00029	CcSEcCtD
Rivastigmine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000107	0.00029	CcSEcCtD
Rivastigmine—Infestation NOS—Doxorubicin—pancreatic cancer	0.000107	0.00029	CcSEcCtD
Rivastigmine—Infestation—Doxorubicin—pancreatic cancer	0.000107	0.00029	CcSEcCtD
Rivastigmine—Drowsiness—Doxorubicin—pancreatic cancer	0.000107	0.00029	CcSEcCtD
Rivastigmine—Tachycardia—Docetaxel—pancreatic cancer	0.000107	0.000289	CcSEcCtD
Rivastigmine—Skin disorder—Docetaxel—pancreatic cancer	0.000106	0.000287	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000106	0.000287	CcSEcCtD
Rivastigmine—Bradycardia—Epirubicin—pancreatic cancer	0.000106	0.000286	CcSEcCtD
Rivastigmine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000105	0.000285	CcSEcCtD
Rivastigmine—Renal failure—Doxorubicin—pancreatic cancer	0.000105	0.000285	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000105	0.000284	CcSEcCtD
Rivastigmine—Dizziness—Irinotecan—pancreatic cancer	0.000105	0.000283	CcSEcCtD
Rivastigmine—Haemoglobin—Epirubicin—pancreatic cancer	0.000104	0.000282	CcSEcCtD
Rivastigmine—Anorexia—Docetaxel—pancreatic cancer	0.000104	0.000282	CcSEcCtD
Rivastigmine—Rhinitis—Epirubicin—pancreatic cancer	0.000104	0.000282	CcSEcCtD
Rivastigmine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000104	0.000281	CcSEcCtD
Rivastigmine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000104	0.000281	CcSEcCtD
Rivastigmine—Haemorrhage—Epirubicin—pancreatic cancer	0.000104	0.000281	CcSEcCtD
Rivastigmine—Hepatitis—Epirubicin—pancreatic cancer	0.000104	0.000281	CcSEcCtD
Rivastigmine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000104	0.000281	CcSEcCtD
Rivastigmine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000103	0.00028	CcSEcCtD
Rivastigmine—Pharyngitis—Epirubicin—pancreatic cancer	0.000103	0.000279	CcSEcCtD
Rivastigmine—Sweating—Doxorubicin—pancreatic cancer	0.000103	0.000278	CcSEcCtD
Rivastigmine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000103	0.000277	CcSEcCtD
Rivastigmine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000102	0.000277	CcSEcCtD
Rivastigmine—Hypotension—Docetaxel—pancreatic cancer	0.000102	0.000277	CcSEcCtD
Rivastigmine—Haematuria—Doxorubicin—pancreatic cancer	0.000102	0.000276	CcSEcCtD
Rivastigmine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000102	0.000276	CcSEcCtD
Rivastigmine—Urethral disorder—Epirubicin—pancreatic cancer	0.000102	0.000275	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000101	0.000274	CcSEcCtD
Rivastigmine—Epistaxis—Doxorubicin—pancreatic cancer	0.000101	0.000273	CcSEcCtD
Rivastigmine—Vomiting—Irinotecan—pancreatic cancer	0.000101	0.000272	CcSEcCtD
Rivastigmine—Sinusitis—Doxorubicin—pancreatic cancer	0.0001	0.000272	CcSEcCtD
Rivastigmine—Dizziness—Fluorouracil—pancreatic cancer	0.0001	0.000271	CcSEcCtD
Rivastigmine—Visual impairment—Epirubicin—pancreatic cancer	0.0001	0.000271	CcSEcCtD
Rivastigmine—Rash—Irinotecan—pancreatic cancer	9.97e-05	0.00027	CcSEcCtD
Rivastigmine—Dermatitis—Irinotecan—pancreatic cancer	9.97e-05	0.00027	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	9.96e-05	0.00027	CcSEcCtD
Rivastigmine—Headache—Irinotecan—pancreatic cancer	9.91e-05	0.000268	CcSEcCtD
Rivastigmine—Insomnia—Docetaxel—pancreatic cancer	9.89e-05	0.000268	CcSEcCtD
Rivastigmine—Paraesthesia—Docetaxel—pancreatic cancer	9.82e-05	0.000266	CcSEcCtD
Rivastigmine—Erythema multiforme—Epirubicin—pancreatic cancer	9.82e-05	0.000266	CcSEcCtD
Rivastigmine—Vomiting—Gemcitabine—pancreatic cancer	9.8e-05	0.000265	CcSEcCtD
Rivastigmine—Bradycardia—Doxorubicin—pancreatic cancer	9.78e-05	0.000265	CcSEcCtD
Rivastigmine—Dyspnoea—Docetaxel—pancreatic cancer	9.75e-05	0.000264	CcSEcCtD
Rivastigmine—Somnolence—Docetaxel—pancreatic cancer	9.72e-05	0.000263	CcSEcCtD
Rivastigmine—Rash—Gemcitabine—pancreatic cancer	9.72e-05	0.000263	CcSEcCtD
Rivastigmine—Dermatitis—Gemcitabine—pancreatic cancer	9.71e-05	0.000263	CcSEcCtD
Rivastigmine—Eye disorder—Epirubicin—pancreatic cancer	9.7e-05	0.000263	CcSEcCtD
Rivastigmine—Tinnitus—Epirubicin—pancreatic cancer	9.68e-05	0.000262	CcSEcCtD
Rivastigmine—Haemoglobin—Doxorubicin—pancreatic cancer	9.66e-05	0.000261	CcSEcCtD
Rivastigmine—Headache—Gemcitabine—pancreatic cancer	9.65e-05	0.000261	CcSEcCtD
Rivastigmine—Cardiac disorder—Epirubicin—pancreatic cancer	9.64e-05	0.000261	CcSEcCtD
Rivastigmine—Flushing—Epirubicin—pancreatic cancer	9.64e-05	0.000261	CcSEcCtD
Rivastigmine—Vomiting—Fluorouracil—pancreatic cancer	9.63e-05	0.000261	CcSEcCtD
Rivastigmine—Rhinitis—Doxorubicin—pancreatic cancer	9.63e-05	0.000261	CcSEcCtD
Rivastigmine—Dyspepsia—Docetaxel—pancreatic cancer	9.63e-05	0.000261	CcSEcCtD
Rivastigmine—Haemorrhage—Doxorubicin—pancreatic cancer	9.61e-05	0.00026	CcSEcCtD
Rivastigmine—Hepatitis—Doxorubicin—pancreatic cancer	9.61e-05	0.00026	CcSEcCtD
Rivastigmine—Hypoaesthesia—Doxorubicin—pancreatic cancer	9.56e-05	0.000259	CcSEcCtD
Rivastigmine—Rash—Fluorouracil—pancreatic cancer	9.55e-05	0.000259	CcSEcCtD
Rivastigmine—Dermatitis—Fluorouracil—pancreatic cancer	9.54e-05	0.000258	CcSEcCtD
Rivastigmine—Pharyngitis—Doxorubicin—pancreatic cancer	9.53e-05	0.000258	CcSEcCtD
Rivastigmine—Decreased appetite—Docetaxel—pancreatic cancer	9.51e-05	0.000257	CcSEcCtD
Rivastigmine—Headache—Fluorouracil—pancreatic cancer	9.49e-05	0.000257	CcSEcCtD
Rivastigmine—Urinary tract disorder—Doxorubicin—pancreatic cancer	9.49e-05	0.000257	CcSEcCtD
Rivastigmine—Oedema peripheral—Doxorubicin—pancreatic cancer	9.46e-05	0.000256	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	9.44e-05	0.000256	CcSEcCtD
Rivastigmine—Connective tissue disorder—Doxorubicin—pancreatic cancer	9.44e-05	0.000255	CcSEcCtD
Rivastigmine—Fatigue—Docetaxel—pancreatic cancer	9.43e-05	0.000255	CcSEcCtD
Rivastigmine—Angiopathy—Epirubicin—pancreatic cancer	9.42e-05	0.000255	CcSEcCtD
Rivastigmine—Urethral disorder—Doxorubicin—pancreatic cancer	9.42e-05	0.000255	CcSEcCtD
Rivastigmine—Nausea—Irinotecan—pancreatic cancer	9.4e-05	0.000254	CcSEcCtD
Rivastigmine—Mediastinal disorder—Epirubicin—pancreatic cancer	9.36e-05	0.000253	CcSEcCtD
Rivastigmine—Constipation—Docetaxel—pancreatic cancer	9.35e-05	0.000253	CcSEcCtD
Rivastigmine—Pain—Docetaxel—pancreatic cancer	9.35e-05	0.000253	CcSEcCtD
Rivastigmine—Chills—Epirubicin—pancreatic cancer	9.32e-05	0.000252	CcSEcCtD
Rivastigmine—Arrhythmia—Epirubicin—pancreatic cancer	9.28e-05	0.000251	CcSEcCtD
Rivastigmine—Visual impairment—Doxorubicin—pancreatic cancer	9.26e-05	0.000251	CcSEcCtD
Rivastigmine—Alopecia—Epirubicin—pancreatic cancer	9.17e-05	0.000248	CcSEcCtD
Rivastigmine—Nausea—Gemcitabine—pancreatic cancer	9.15e-05	0.000248	CcSEcCtD
Rivastigmine—Mental disorder—Epirubicin—pancreatic cancer	9.1e-05	0.000246	CcSEcCtD
Rivastigmine—Erythema multiforme—Doxorubicin—pancreatic cancer	9.08e-05	0.000246	CcSEcCtD
Rivastigmine—Erythema—Epirubicin—pancreatic cancer	9.04e-05	0.000245	CcSEcCtD
Rivastigmine—Malnutrition—Epirubicin—pancreatic cancer	9.04e-05	0.000245	CcSEcCtD
Rivastigmine—Feeling abnormal—Docetaxel—pancreatic cancer	9.01e-05	0.000244	CcSEcCtD
Rivastigmine—Nausea—Fluorouracil—pancreatic cancer	9e-05	0.000244	CcSEcCtD
Rivastigmine—Eye disorder—Doxorubicin—pancreatic cancer	8.98e-05	0.000243	CcSEcCtD
Rivastigmine—Tinnitus—Doxorubicin—pancreatic cancer	8.96e-05	0.000242	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Docetaxel—pancreatic cancer	8.94e-05	0.000242	CcSEcCtD
Rivastigmine—Flushing—Doxorubicin—pancreatic cancer	8.92e-05	0.000241	CcSEcCtD
Rivastigmine—Cardiac disorder—Doxorubicin—pancreatic cancer	8.92e-05	0.000241	CcSEcCtD
Rivastigmine—Flatulence—Epirubicin—pancreatic cancer	8.91e-05	0.000241	CcSEcCtD
Rivastigmine—Tension—Epirubicin—pancreatic cancer	8.87e-05	0.00024	CcSEcCtD
Rivastigmine—Dysgeusia—Epirubicin—pancreatic cancer	8.85e-05	0.00024	CcSEcCtD
Rivastigmine—Nervousness—Epirubicin—pancreatic cancer	8.78e-05	0.000238	CcSEcCtD
Rivastigmine—Back pain—Epirubicin—pancreatic cancer	8.74e-05	0.000237	CcSEcCtD
Rivastigmine—Angiopathy—Doxorubicin—pancreatic cancer	8.72e-05	0.000236	CcSEcCtD
Rivastigmine—Muscle spasms—Epirubicin—pancreatic cancer	8.69e-05	0.000235	CcSEcCtD
Rivastigmine—Mediastinal disorder—Doxorubicin—pancreatic cancer	8.66e-05	0.000234	CcSEcCtD
Rivastigmine—Abdominal pain—Docetaxel—pancreatic cancer	8.65e-05	0.000234	CcSEcCtD
Rivastigmine—Body temperature increased—Docetaxel—pancreatic cancer	8.65e-05	0.000234	CcSEcCtD
Rivastigmine—Chills—Doxorubicin—pancreatic cancer	8.62e-05	0.000233	CcSEcCtD
Rivastigmine—Arrhythmia—Doxorubicin—pancreatic cancer	8.58e-05	0.000232	CcSEcCtD
Rivastigmine—Vision blurred—Epirubicin—pancreatic cancer	8.52e-05	0.000231	CcSEcCtD
Rivastigmine—Alopecia—Doxorubicin—pancreatic cancer	8.49e-05	0.00023	CcSEcCtD
Rivastigmine—Mental disorder—Doxorubicin—pancreatic cancer	8.42e-05	0.000228	CcSEcCtD
Rivastigmine—Ill-defined disorder—Epirubicin—pancreatic cancer	8.39e-05	0.000227	CcSEcCtD
Rivastigmine—Erythema—Doxorubicin—pancreatic cancer	8.36e-05	0.000226	CcSEcCtD
Rivastigmine—Malnutrition—Doxorubicin—pancreatic cancer	8.36e-05	0.000226	CcSEcCtD
Rivastigmine—Anaemia—Epirubicin—pancreatic cancer	8.35e-05	0.000226	CcSEcCtD
Rivastigmine—Agitation—Epirubicin—pancreatic cancer	8.31e-05	0.000225	CcSEcCtD
Rivastigmine—Flatulence—Doxorubicin—pancreatic cancer	8.24e-05	0.000223	CcSEcCtD
Rivastigmine—Tension—Doxorubicin—pancreatic cancer	8.21e-05	0.000222	CcSEcCtD
Rivastigmine—Dysgeusia—Doxorubicin—pancreatic cancer	8.19e-05	0.000222	CcSEcCtD
Rivastigmine—Malaise—Epirubicin—pancreatic cancer	8.15e-05	0.000221	CcSEcCtD
Rivastigmine—Nervousness—Doxorubicin—pancreatic cancer	8.12e-05	0.00022	CcSEcCtD
Rivastigmine—Vertigo—Epirubicin—pancreatic cancer	8.12e-05	0.00022	CcSEcCtD
Rivastigmine—Syncope—Epirubicin—pancreatic cancer	8.11e-05	0.000219	CcSEcCtD
Rivastigmine—Back pain—Doxorubicin—pancreatic cancer	8.09e-05	0.000219	CcSEcCtD
Rivastigmine—Hypersensitivity—Docetaxel—pancreatic cancer	8.06e-05	0.000218	CcSEcCtD
Rivastigmine—Muscle spasms—Doxorubicin—pancreatic cancer	8.04e-05	0.000218	CcSEcCtD
Rivastigmine—Palpitations—Epirubicin—pancreatic cancer	7.99e-05	0.000216	CcSEcCtD
Rivastigmine—Loss of consciousness—Epirubicin—pancreatic cancer	7.94e-05	0.000215	CcSEcCtD
Rivastigmine—Cough—Epirubicin—pancreatic cancer	7.89e-05	0.000213	CcSEcCtD
Rivastigmine—Vision blurred—Doxorubicin—pancreatic cancer	7.88e-05	0.000213	CcSEcCtD
Rivastigmine—Asthenia—Docetaxel—pancreatic cancer	7.85e-05	0.000212	CcSEcCtD
Rivastigmine—Convulsion—Epirubicin—pancreatic cancer	7.83e-05	0.000212	CcSEcCtD
Rivastigmine—Hypertension—Epirubicin—pancreatic cancer	7.8e-05	0.000211	CcSEcCtD
Rivastigmine—Ill-defined disorder—Doxorubicin—pancreatic cancer	7.76e-05	0.00021	CcSEcCtD
Rivastigmine—Pruritus—Docetaxel—pancreatic cancer	7.74e-05	0.000209	CcSEcCtD
Rivastigmine—Anaemia—Doxorubicin—pancreatic cancer	7.73e-05	0.000209	CcSEcCtD
Rivastigmine—Myalgia—Epirubicin—pancreatic cancer	7.69e-05	0.000208	CcSEcCtD
Rivastigmine—Arthralgia—Epirubicin—pancreatic cancer	7.69e-05	0.000208	CcSEcCtD
Rivastigmine—Chest pain—Epirubicin—pancreatic cancer	7.69e-05	0.000208	CcSEcCtD
Rivastigmine—Agitation—Doxorubicin—pancreatic cancer	7.69e-05	0.000208	CcSEcCtD
Rivastigmine—Anxiety—Epirubicin—pancreatic cancer	7.67e-05	0.000208	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	7.64e-05	0.000207	CcSEcCtD
Rivastigmine—Discomfort—Epirubicin—pancreatic cancer	7.6e-05	0.000206	CcSEcCtD
Rivastigmine—Malaise—Doxorubicin—pancreatic cancer	7.54e-05	0.000204	CcSEcCtD
Rivastigmine—Dry mouth—Epirubicin—pancreatic cancer	7.53e-05	0.000204	CcSEcCtD
Rivastigmine—Vertigo—Doxorubicin—pancreatic cancer	7.51e-05	0.000203	CcSEcCtD
Rivastigmine—Syncope—Doxorubicin—pancreatic cancer	7.5e-05	0.000203	CcSEcCtD
Rivastigmine—Diarrhoea—Docetaxel—pancreatic cancer	7.48e-05	0.000202	CcSEcCtD
Rivastigmine—Confusional state—Epirubicin—pancreatic cancer	7.44e-05	0.000201	CcSEcCtD
Rivastigmine—Palpitations—Doxorubicin—pancreatic cancer	7.39e-05	0.0002	CcSEcCtD
Rivastigmine—Oedema—Epirubicin—pancreatic cancer	7.38e-05	0.0002	CcSEcCtD
Rivastigmine—Loss of consciousness—Doxorubicin—pancreatic cancer	7.35e-05	0.000199	CcSEcCtD
Rivastigmine—Infection—Epirubicin—pancreatic cancer	7.33e-05	0.000198	CcSEcCtD
Rivastigmine—Cough—Doxorubicin—pancreatic cancer	7.3e-05	0.000197	CcSEcCtD
Rivastigmine—Shock—Epirubicin—pancreatic cancer	7.26e-05	0.000196	CcSEcCtD
Rivastigmine—Convulsion—Doxorubicin—pancreatic cancer	7.25e-05	0.000196	CcSEcCtD
Rivastigmine—Nervous system disorder—Epirubicin—pancreatic cancer	7.23e-05	0.000196	CcSEcCtD
Rivastigmine—Dizziness—Docetaxel—pancreatic cancer	7.23e-05	0.000196	CcSEcCtD
Rivastigmine—Thrombocytopenia—Epirubicin—pancreatic cancer	7.22e-05	0.000195	CcSEcCtD
Rivastigmine—Hypertension—Doxorubicin—pancreatic cancer	7.22e-05	0.000195	CcSEcCtD
Rivastigmine—Tachycardia—Epirubicin—pancreatic cancer	7.2e-05	0.000195	CcSEcCtD
Rivastigmine—Skin disorder—Epirubicin—pancreatic cancer	7.16e-05	0.000194	CcSEcCtD
Rivastigmine—Hyperhidrosis—Epirubicin—pancreatic cancer	7.13e-05	0.000193	CcSEcCtD
Rivastigmine—Arthralgia—Doxorubicin—pancreatic cancer	7.12e-05	0.000193	CcSEcCtD
Rivastigmine—Chest pain—Doxorubicin—pancreatic cancer	7.12e-05	0.000193	CcSEcCtD
Rivastigmine—Myalgia—Doxorubicin—pancreatic cancer	7.12e-05	0.000193	CcSEcCtD
Rivastigmine—Anxiety—Doxorubicin—pancreatic cancer	7.1e-05	0.000192	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	7.07e-05	0.000191	CcSEcCtD
Rivastigmine—Discomfort—Doxorubicin—pancreatic cancer	7.03e-05	0.00019	CcSEcCtD
Rivastigmine—Anorexia—Epirubicin—pancreatic cancer	7.03e-05	0.00019	CcSEcCtD
Rivastigmine—Dry mouth—Doxorubicin—pancreatic cancer	6.96e-05	0.000188	CcSEcCtD
Rivastigmine—Vomiting—Docetaxel—pancreatic cancer	6.95e-05	0.000188	CcSEcCtD
Rivastigmine—Rash—Docetaxel—pancreatic cancer	6.9e-05	0.000187	CcSEcCtD
Rivastigmine—Hypotension—Epirubicin—pancreatic cancer	6.89e-05	0.000187	CcSEcCtD
Rivastigmine—Dermatitis—Docetaxel—pancreatic cancer	6.89e-05	0.000186	CcSEcCtD
Rivastigmine—Confusional state—Doxorubicin—pancreatic cancer	6.88e-05	0.000186	CcSEcCtD
Rivastigmine—Headache—Docetaxel—pancreatic cancer	6.85e-05	0.000185	CcSEcCtD
Rivastigmine—Oedema—Doxorubicin—pancreatic cancer	6.83e-05	0.000185	CcSEcCtD
Rivastigmine—Infection—Doxorubicin—pancreatic cancer	6.78e-05	0.000183	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	6.72e-05	0.000182	CcSEcCtD
Rivastigmine—Shock—Doxorubicin—pancreatic cancer	6.71e-05	0.000182	CcSEcCtD
Rivastigmine—Nervous system disorder—Doxorubicin—pancreatic cancer	6.69e-05	0.000181	CcSEcCtD
Rivastigmine—Thrombocytopenia—Doxorubicin—pancreatic cancer	6.68e-05	0.000181	CcSEcCtD
Rivastigmine—Insomnia—Epirubicin—pancreatic cancer	6.67e-05	0.000181	CcSEcCtD
Rivastigmine—Tachycardia—Doxorubicin—pancreatic cancer	6.66e-05	0.00018	CcSEcCtD
Rivastigmine—Skin disorder—Doxorubicin—pancreatic cancer	6.63e-05	0.000179	CcSEcCtD
Rivastigmine—Paraesthesia—Epirubicin—pancreatic cancer	6.62e-05	0.000179	CcSEcCtD
Rivastigmine—Hyperhidrosis—Doxorubicin—pancreatic cancer	6.6e-05	0.000179	CcSEcCtD
Rivastigmine—Dyspnoea—Epirubicin—pancreatic cancer	6.58e-05	0.000178	CcSEcCtD
Rivastigmine—Somnolence—Epirubicin—pancreatic cancer	6.56e-05	0.000177	CcSEcCtD
Rivastigmine—Anorexia—Doxorubicin—pancreatic cancer	6.51e-05	0.000176	CcSEcCtD
Rivastigmine—Nausea—Docetaxel—pancreatic cancer	6.5e-05	0.000176	CcSEcCtD
Rivastigmine—Dyspepsia—Epirubicin—pancreatic cancer	6.49e-05	0.000176	CcSEcCtD
Rivastigmine—Decreased appetite—Epirubicin—pancreatic cancer	6.41e-05	0.000174	CcSEcCtD
Rivastigmine—Hypotension—Doxorubicin—pancreatic cancer	6.38e-05	0.000173	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	6.37e-05	0.000172	CcSEcCtD
Rivastigmine—Fatigue—Epirubicin—pancreatic cancer	6.36e-05	0.000172	CcSEcCtD
Rivastigmine—Constipation—Epirubicin—pancreatic cancer	6.31e-05	0.000171	CcSEcCtD
Rivastigmine—Pain—Epirubicin—pancreatic cancer	6.31e-05	0.000171	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	6.22e-05	0.000168	CcSEcCtD
Rivastigmine—Insomnia—Doxorubicin—pancreatic cancer	6.17e-05	0.000167	CcSEcCtD
Rivastigmine—Paraesthesia—Doxorubicin—pancreatic cancer	6.13e-05	0.000166	CcSEcCtD
Rivastigmine—Dyspnoea—Doxorubicin—pancreatic cancer	6.08e-05	0.000165	CcSEcCtD
Rivastigmine—Feeling abnormal—Epirubicin—pancreatic cancer	6.08e-05	0.000164	CcSEcCtD
Rivastigmine—Somnolence—Doxorubicin—pancreatic cancer	6.07e-05	0.000164	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.03e-05	0.000163	CcSEcCtD
Rivastigmine—Dyspepsia—Doxorubicin—pancreatic cancer	6.01e-05	0.000163	CcSEcCtD
Rivastigmine—Decreased appetite—Doxorubicin—pancreatic cancer	5.93e-05	0.000161	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	5.89e-05	0.000159	CcSEcCtD
Rivastigmine—Fatigue—Doxorubicin—pancreatic cancer	5.88e-05	0.000159	CcSEcCtD
Rivastigmine—Urticaria—Epirubicin—pancreatic cancer	5.86e-05	0.000159	CcSEcCtD
Rivastigmine—Pain—Doxorubicin—pancreatic cancer	5.84e-05	0.000158	CcSEcCtD
Rivastigmine—Constipation—Doxorubicin—pancreatic cancer	5.84e-05	0.000158	CcSEcCtD
Rivastigmine—Abdominal pain—Epirubicin—pancreatic cancer	5.83e-05	0.000158	CcSEcCtD
Rivastigmine—Body temperature increased—Epirubicin—pancreatic cancer	5.83e-05	0.000158	CcSEcCtD
Rivastigmine—Feeling abnormal—Doxorubicin—pancreatic cancer	5.62e-05	0.000152	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	5.58e-05	0.000151	CcSEcCtD
Rivastigmine—Hypersensitivity—Epirubicin—pancreatic cancer	5.43e-05	0.000147	CcSEcCtD
Rivastigmine—Urticaria—Doxorubicin—pancreatic cancer	5.42e-05	0.000147	CcSEcCtD
Rivastigmine—Body temperature increased—Doxorubicin—pancreatic cancer	5.4e-05	0.000146	CcSEcCtD
Rivastigmine—Abdominal pain—Doxorubicin—pancreatic cancer	5.4e-05	0.000146	CcSEcCtD
Rivastigmine—Asthenia—Epirubicin—pancreatic cancer	5.29e-05	0.000143	CcSEcCtD
Rivastigmine—Pruritus—Epirubicin—pancreatic cancer	5.22e-05	0.000141	CcSEcCtD
Rivastigmine—Diarrhoea—Epirubicin—pancreatic cancer	5.05e-05	0.000137	CcSEcCtD
Rivastigmine—Hypersensitivity—Doxorubicin—pancreatic cancer	5.03e-05	0.000136	CcSEcCtD
Rivastigmine—Asthenia—Doxorubicin—pancreatic cancer	4.9e-05	0.000133	CcSEcCtD
Rivastigmine—Dizziness—Epirubicin—pancreatic cancer	4.88e-05	0.000132	CcSEcCtD
Rivastigmine—Pruritus—Doxorubicin—pancreatic cancer	4.83e-05	0.000131	CcSEcCtD
Rivastigmine—Vomiting—Epirubicin—pancreatic cancer	4.69e-05	0.000127	CcSEcCtD
Rivastigmine—Diarrhoea—Doxorubicin—pancreatic cancer	4.67e-05	0.000126	CcSEcCtD
Rivastigmine—Rash—Epirubicin—pancreatic cancer	4.65e-05	0.000126	CcSEcCtD
Rivastigmine—Dermatitis—Epirubicin—pancreatic cancer	4.65e-05	0.000126	CcSEcCtD
Rivastigmine—Headache—Epirubicin—pancreatic cancer	4.62e-05	0.000125	CcSEcCtD
Rivastigmine—Dizziness—Doxorubicin—pancreatic cancer	4.51e-05	0.000122	CcSEcCtD
Rivastigmine—Nausea—Epirubicin—pancreatic cancer	4.38e-05	0.000119	CcSEcCtD
Rivastigmine—Vomiting—Doxorubicin—pancreatic cancer	4.34e-05	0.000117	CcSEcCtD
Rivastigmine—Rash—Doxorubicin—pancreatic cancer	4.3e-05	0.000116	CcSEcCtD
Rivastigmine—Dermatitis—Doxorubicin—pancreatic cancer	4.3e-05	0.000116	CcSEcCtD
Rivastigmine—Headache—Doxorubicin—pancreatic cancer	4.28e-05	0.000116	CcSEcCtD
Rivastigmine—Nausea—Doxorubicin—pancreatic cancer	4.05e-05	0.00011	CcSEcCtD
